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Abstract
Functional genomics and forward genetics seek to assign function to all known genes in a genome. Entamoeba histolytica is
a protozoan parasite for which forward genetics approaches have not been extensively applied. It is the causative agent of
amoebic dysentery and liver abscess, and infection is prevalent in developing countries that cannot prevent its fecal-oral
spread. It is responsible for considerable global morbidity and mortality. Given that the E. histolytica genome has been
sequenced, it should be possible to apply genomic approaches to discover gene function. We used a genome-wide over-
expression screen to uncover genes regulating an important virulence function of E. histolytica, namely phagocytosis. We
developed an episomal E. histolytica cDNA over-expression library, transfected the collection of plasmids into trophozoites,
and applied a high-throughput screen to identify phagocytosis mutants in the population of over-expressing cells. The
screen was based on the phagocytic uptake of human red blood cells loaded with the metabolic toxin, tubercidin.
Expression plasmids were isolated from trophozoites that survived exposure to tubercidin-charged erythrocytes
(phagocytosis mutants), and the cDNAs were sequenced. We isolated the gene encoding profilin, a well-characterized
cytoskeleton-regulating protein with a known role in phagocytosis. This supports the validity of our approach. Furthermore,
we assigned a phagocytic role to several genes not previously known to function in this manner. To our knowledge, this is
the first genome-wide forward genetics screen to be applied to this pathogen. The study demonstrates the power of
forward genetics in revealing genes regulating virulence in E. histolytica. In addition, the study validates an E. histolytica
cDNA over-expression library as a valuable tool for functional genomics.
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Introduction
Functional genomics is a branch of molecular biology that seeks
to assign roles to all known genes in a genome. It encompasses
a wide variety of techniques which may be classified as reverse or
forward genetics. Reverse genetics begins by mutating a gene of
interest. Subsequently, mechanisms of gene action may be
uncovered by observing the ensuing phenotypic changes. On the
other hand, forward genetics techniques begin with a mutant
phenotype of interest; altered genes contributing to this phenotype
are then identified. With the completion of genome sequences for
many organisms, it is now possible to perform genome-wide
reverse or forward genetics screens to uncover novel genes
regulating known cellular processes.
Genome-wide over-expression screens represent one of many
types of forward genetics approaches (reviewed in [1]). This
method uses low- to high-throughput selection schemes to identify
and select for certain phenotypes in populations of cells over-
expressing all or a subset of genes from the genome. Genes that
have been identified by over-expression screens include, but are
not limited to, those that regulate the action of small-molecules [2],
the cell cycle [3,4], oxidative stress-induced damage [5], endocytic
vesicle trafficking [6], and development [7]. Thus, it is clear that
forward genetics and over-expression screens represent a powerful
approach for gene discovery.
Entamoeba histolytica is a protozoan parasite for which forward
genetics approaches have not been extensively applied. It is
causative agent of amoebic dysentery and liver abscess (reviewed
in [8]) and is prevalent in developing countries that cannot prevent
its fecal-oral spread. The pathogen is responsible for considerable
global morbidity and mortality. Infection is acquired by ingestion
of the cyst form of the parasite. Excystation occurs in the small
intestine; released amoeboid trophozoites move to, and colonize,
the bowel lumen. Here, the pathogen acquires nutrients via
phagocytosis of colonic bacteria, host cells including red blood cells
(RBCs), and host cell debris. The ability of the pathogen to carry
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out phagocytosis has been correlated to its virulence potential. For
example, phagocytosis-deficient mutants of E. histolytica exhibit
reduced pathogenicity in vitro and in vivo [9,10], and a non-invasive
Entamoeba species, E. dispar, exhibits low rates of phagocytosis [11].
Phagocytosis is a complex cellular activity that relies on the
coordinated regulation of signal transduction, cytoskeletal re-
arrangement, and membrane remodeling. Given the importance
of phagocytosis to E. histolytica virulence, the identification of
proteins that directly or indirectly regulate this process has been
the focus of a considerable research effort (reviewed in [12,13]).
Proteomic analyses have identified numerous proteins associated
with purified phagosomes of E. histolytica [13–17]. However,
discerning the exact functions of these genes in phagoctyosis
requires additional experimentation.
The genome of E. histolytica has been sequenced [18]. Thus, it
may be possible to apply functional genomics approaches to
identify genes regulating virulence functions, such as phagocytosis.
Here, we report on the application of an over-expression screen to
discover genes regulating phagocytic trafficking. Specifically, we
adapted a high-throughput scheme [19] that relied on a loss-of-
function phenotype (reduced phagocytosis) to uncover genes that,
when over-expressed, negatively regulate phagocytosis. We un-
covered the gene encoding profilin, a well-characterized cytoskel-
eton-regulating protein with a known role in phagocytosis [20].
This supports the validity of our approach. Furthermore, we
assigned a phagocytic role to several genes not previously known to
function in this manner. This study demonstrates that is possible to
use forward genetics for gene discovery in this important global
pathogen.
Methods
Strains and Culture Conditions
Entamoeba histolytica trophozoites (strain HM-1:IMSS) were
cultured axenically in TYI-S-33 media [21] in 15 ml glass screw
cap tubes at 37uC. The generation of E. histolytica cell lines
conditionally over-expressing green fluorescent protein (GFP) or
a GFP-tagged pleckstrin homology domain from mammalian
Bruton’s tyrosine kinase (GFP-PHBtk) is described elsewhere [22].
These two transgenic cell lines were maintained in TYI-S-33
supplemented with 6 mg/ml G418 and 15 mg/ml hygromycin.
GFP or GFP-PHBtk expression was induced by the addition of
5 mg/ml tetracycline to the culture medium 24 hours prior to
performing assays.
Construction of a cDNA Expression Library and
Transfection
An E. histolytica cDNA library was constructed using Invitrogen
Custom Services (Invitrogen, Carlsbad, CA). Briefly, RNA was
isolated from approximately 2.46107 trophozoites using TrizolH
Reagent (Invitrogen) according to the manufacturer’s protocol.
Poly(A)+-RNA was selected from 2 mg total RNA and used to
generate a primary, uncut, 7-fold normalized cDNA library,
directionally cloned into the GatewayH compatible entry vector,
pENTRTM222 (f1-). Proprietary 59 cap-binding technology was
used to select and enrich for full-length clones. The final titer of the
amplified library was 3.96106 colony-forming units/ml. Twenty-
four random clones, with a minimum of 20 different genes, were
analyzed for the presence of inserts. All 24 clones had inserts with
an average size of 1.1 kb.
The LR Clonase system (Invitrogen) was used to transfer cDNA
inserts from pENTRTM222 to pAH-DEST [23], a Gateway-
compatible E. histolytica expression vector (kind gift from C.A.
Gilchrist and W.A. Petri, Jr., Dept. of Medicine, Division of
Infectious Diseases and International Health, University of
Virginia, Charlottesville, VA), using manufacturer’s instructions.
This plasmid is episomal in nature [24] and confers hygromycin-
resistance to transfectants. Expression from this plasmid is driven
by upstream ferredoxin regulatory sequences. The cDNA library
in pAH-DEST was transfected into HM1:IMSS trophozoites
using standard protocols [22,25]. Transfectants were maintained
by the addition of 23 mg/ml hygromycin to the medium.
Development of a Screen for Phagocytosis Mutants
Human red blood cells (hRBCs) (US Biological Inc., Swamps-
cott, MA) were washed three times with phosphate-buffered saline
(PBS) and resuspended to 5% (vol/vol) in PBS. Subsequently,
erythrocytes were exposed to tubercidin (7-deazaadenosine)
(500 mg/ml) (Sigma, St. Louis, MO) or an equivalent volume of
DMSO (diluent) for 1 hour at 37uC. The treated erythrocytes were
washed five times in PBS and resuspended to 0.5% (vol/vol) in
serum-free trophozoite medium. Log-phase trophozoites
(1.56105 cells/ml) were exposed to the tubercidin-loaded hRBCs
for 30 minutes at 37uC at a ratio of ,100 hRBCs:1 amoeba. This
ratio represents saturation of erythrophagocytic receptors in E.
histolytica [26]. After incubation, the trophozoites and hRBCs were
collected by centrifugation (5006g, 1 minute) and un-internalized
hRBCs were hypotonically lysed by the addition of distilled water
to the pellets. The trophozoites were washed with PBS,
resuspended in TYI-S-33 medium, and incubated at 37uC.
Trophozoites were allowed to recover for 1 hour, after which,
the selection scheme was repeated once (for a total of 2 treatments)
or twice (for a total of 3 treatments). Finally, trophozoites were
incubated at 37uC for 24 to 48 hours. Cell viability was measured
by microscopy with Trypan Blue exclusion.
Isolation of Episomes from Survivors and Sequencing
Total DNA was isolated from unselected control cells and cells
that survived selection using the Wizard Genomic DNA Purifica-
tion Kit (Promega, Madison, WI). The isolated DNA was
introduced into Escherichia coli (XL10-GOLD, Stratagene, La Jolla,
CA) by standard transformation protocols resulting in ampicillin-
resistant bacterial colonies. Bacterial colonies were randomly
chosen from each condition (control or tubercidin-selection),
transferred to the wells of 96-well plates containing LB medium
supplemented with ampicillin (100 mg/ml) and glycerol (50% vol/
vol) and stored at 280uC prior to automated sequencing at the
Arizona State University BioDesign Institute (Tempe, AZ).
Analysis of Expression by Quantitative Real-Time PCR
E. histolytica cells were transfected with the expression plasmids
encoding H644 or EhLimA using standard methods [22,25]. The
transfectants were grown to mid log phase (36105 cells/ml). Total
RNA was isolated with TrizolH Reagent, and 2 mg RNA was
treated with DNAase I for 30 minutes at 37uC. cDNA was
synthesized with oligo-dT and Superscript III reverse transcriptase
(Invitrogen) at 50uC for 2 hours.
Expression of H644 or EhLimA was measured by quantitative
real-time PCR (qPCR) using the RT2 SYBR Green Fluor qPCR
Mastermix (SABiosciences, Frederick, MD) and the appropriate
primers for EhLimA (forward primer 59-TGGTGATTCTAGT-
GAACGCCGTGA-39; reverse primer 59-TCATG-
TACCTCTTCTTCGTGAACT-39) and H644 (forward primer
59-GCTACCGTTGCTGAAGATAGAGCAAGAC-39; reverse
primer 59-GCAATGCTATCTCTGAATGGAGCAG-39). Levels
of cDNA were normalized using the small subunit ribosomal RNA
(ssRNA) gene (Accession No. X61116) as a housekeeping gene
[27] (forward primer 59-AGGCGCGTAAATTACC-
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CACTTTCG-39; reverse primer 59-CACCAGACTTGCCCTC-
CAATTGAT-39) and ratios were calculated using the Pfaffl
method [28]. qPCR was performed using an IQ5 I-Cycler (Bio-
Rad Laboratories Inc., Hercules, CA). Two independent bi-
ological replicates were evaluated. For each cDNA three technical
replicates were performed and the values averaged. The efficiency
of each primer pair was assessed by use of a dilution series. In
all cases, efficiency values were $88.2% and R2 values were
$0.989.
Erythrophagocytosis Assay
Measurement of erythrophagocytosis, using human erythro-
cytes, was carried out according to the methods of Voigt et al. [29]
with modifications. Erythrocytes were washed 3 times by
centrifugation with serum-free amoeba culture medium to
eliminate endogenous serum and then resuspended in serum-free
amoeba culture medium. E. histolytica cells were washed with
serum-free amoeba culture medium. Amoebae (26105) were
incubated with hRBCs (ratio of hRBCs:amoebae; 100:1) at 37uC
in 0.2 ml serum-free amoeba culture medium for 10 minutes. The
amoebae and erythrocytes were then centrifuged and resuspended
in 2 ml cold sterile water to lyse non-ingested hRBCs. After
a second centrifugation step, the pellet contained only amoebae
with internalized hRBCs. The pellet was washed with PBS and
resuspended in 1 ml concentrated formic acid. Samples were
measured against a formic acid blank with a mQuant spectropho-
tometer plate reader (Bio-Tek, Winooski, VT) at 405 nm.
Phagocytosis was reported as the percent of uptake by un-
transfected control cells, which was arbitrarily set to 100%.
Fluid Phase Endoctyosis Assay
E. histolytica cells, suspended in serum-free medium, were
exposed to 5 mg/ml fluorescein isothiocyanate-dextran (FITC-
dextran; 40 kDa) (Sigma, St. Louis, MO) in serum-free medium
and incubated for 30 minutes at 37uC. The amoebae were
collected by centrifugation, washed twice in ice-cold PBS, and
lysed by the addition of 2.5% (vol/vol) Triton X-100 in PBS. Total
fluorescence of the samples was measured using an FLx800
microplate fluorescence reader (Bio-Tek) with excitation and
emission wavelengths of 485 nm and 528 nm, respectively.
Endocytosis was reported as the percent of uptake by un-
transfected control cells, which was arbitrarily set to 100%.
Cycloheximide-Sensitivity Assay
E. histolytica trophozoites (36104 cells) were seeded into 13 mL
of TYI-S-33 supplemented with 100 nM cycloheximide or an
equivalent volume of PBS (diluent). The cells were incubated at
37uC for 48 hours after which viability was assessed by microscopy
with Trypan-blue exclusion.
Statistical and In Silico Analyses
All values are given as a mean 6 standard deviation (S.D.) of at
least 3 trials. To compare means, statistical analyses were
performed using GraphPad InstatH V.3 with an unpaired t-test,
Welch corrected (two-tail P-value). To compare the composition of
the gene set obtained before and after selection we used a modified
x2 test of independence, known as a G-test [30]. In all cases, P-
values less than 0.05 were considered statistically significant and
were denoted by a single asterisk (*). P-values less than 0.01 or
0.001 were considered highly statistically significant and were
denoted by two (**) or three (***) asterisks, respectively. To identify
structural and functional residues and domains, the predicted
amino acid sequences of the H644 and EhLimA proteins were
analyzed using ExPASy ScanPROSITE [31]. Cartoon renderings
of the H644 and EhLimA proteins were generated using the
MyDomains-Image Creator in ExPASy PROSITE.
Results
Development of a Screen to Enrich for Phagocytosis
Mutants
Tubercidin is a cytotoxic adenosine analog isolated from
Streptomyces tubercidus. Its mode of action is related to its ability to
inhibit glycolysis [32] and/or intercalate into DNA [33].
Tubercidin readily permeates erythrocytes whereupon it is
converted to a membrane impermeant phosphorylated form
[34]. Tubercidin-loaded erythrocytes have been used to isolate
phagocytosis mutants from a population of chemically mutagen-
ized macrophages [19]. To determine if tubercidin-charged
erythrocytes could be used to identify E. histolytica phagocytosis
mutants, we assessed the toxicity of this selection agent on
trophozoites. Amoebae were exposed to toxin-loaded hRBCs and
the viability of the trophozoites was assessed.
Three treatments of E. histolytica cells with tubercidin-charged
hRBCs resulted in the death of nearly 100% of the cells 48 hours
after application of selection (Fig. 1). This level of toxicity
suggested that this selection regimen may be useful in isolating
phagoctyosis mutants from a population of E. histolytica cells. Single
(data not shown) and double exposures (Fig. 1) to tubercidin-
loaded hRBCs were not sufficient to achieve near 100% death. For
example, 2 treatments with tubercidin-loaded hRBCs resulted in
68612% and 11.563.9% viability 24 and 48 hours after selection,
respectively (Fig. 1). Multiple rounds of exposure to toxin-loaded
erythrocytes were also required to achieve high levels of cell death
in macrophages [19]. As a control, we also exposed E. histolytica
cells to hRBCs treated with the tubercidin vehicle, DMSO. This
did not decrease viability of the trophozoites suggesting the killing
was specific to tubercidin (data not shown).
Validation of the Screen Using a Known Phagocytosis
Mutant
To validate the selection scheme, we assessed the toxicity of
tubercidin-loaded hRBCs on an E. histolytica cell line with a known
defect in phagocytosis. We used a transgenic cell line expressing
a GFP-tagged version of a pleckstrin homology (PH) domain from
mammalian Bruton’s tyrosine kinase (GFP-PHBtk) [22]. This
mutant exhibits a 69% reduction in phagocytosis when compared
to a control GFP-expressing cell line [22]. However, the GFP-
PHBtk-expressing cell line displays normal fluid-phase endocytosis
[22]. Tubercidin-loaded hRBCs were less toxic to the cell line
expressing GFP-PHBtk as compared to a cell line expressing GFP
alone (Fig. 2). This indicates that our selection scheme may be
used to enrich for phagocytosis mutants from a population of cells.
Since the mutant showed a high level of survival in the presence of
selection, it suggests that there is negligible free residual tubercidin
being taken up by fluid-phase endocytosis, an alternative endocytic
pathway that is normal in this mutant.
Screening with Tubercidin-Charged Erythrocytes
Identifies Proteins That May Function in Phagocytosis
E. histolytica cells were transformed with a cDNA over-
expression library constructed in the episomal pAH-DEST
expression vector [23]. Expression from this vector is constitutively
by sequences derived from the upstream region of the E. histolytica
ferredoxin gene [24]. Given the high level of toxicity associated
with 3 rounds of selection, the transgenic population of cells was
Forward Genetics and E. histolytica Phagocytosis
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exposed to tubercidin-loaded hRBCs 3 times as described above.
After a 48 hour recovery period, surviving trophozoites were lysed
and over-expressed cDNAs were identified by purification of
episomes, amplification of episomes in E. coli, and sequencing. As
a control, episomes were also isolated and sequenced from the
transgenic population of trophozoites that was not subjected to
selection.
Table 1 shows the identity and frequency of cDNAs isolated
from trophozoites that survived selection as compared to those
recovered randomly from a population of over-expressing cells not
subjected to selection. To determine if the set of genes enriched
after selection was significantly different from that in the control
population, we used a modified x2 test of independence, known as
a G-test. We determined that the set of genes isolated by selection
Figure 1. Tubercidin-loaded erythrocytes are toxic to E. histolytica. Trophozoites were exposed to tubercidin-loaded erythrocytes two or
three times (# of Treatments) and viability was assessed 24 hours or 48 hours after treatment. The data are reported as a percent of the starting
number of viable amoebae before treatment. The data represent the mean 6 S.D of $3 trials (***P,0.001). Three treatments of E. histolytica cells
with tubercidin-charged hRBCs resulted in the death of nearly 100% of the cells 48 hours after application of selection.
doi:10.1371/journal.pone.0043025.g001
Figure 2. Tubercidin-loaded erythrocytes are less toxic to an E. histolytica cell line with a phagocytosis defect. Trophozoites over-
expressing a GFP-tagged version of a pleckstrin homology (PH) domain from mammalian Bruton’s tyrosine kinase (GFP-PHBtk), which exhibit reduced
phagocytosis [22] or a control cell line over-expressing GFP alone (GFP) were exposed to tubercidin-loaded erythrocytes three times and viability was
assessed 48 hours after treatment. The data are reported as a percent of the starting number of viable amoebae before treatment. The data represent
the mean 6 S.D of 3 trials. The phagocytic mutant was insensitive to treatment with tubercidin-charged hRBCs as evidenced by .100% survival
(growth) in the presence of selection. This indicates that the selection scheme may be used to enrich for phagocytosis mutants from a population of
cells.
doi:10.1371/journal.pone.0043025.g002
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was extremely statistically different from the set of genes isolated
randomly from the control unselected population (P=4.761027).
This statistical analysis shows strong evidence for a non-fortuitous
enrichment of specific genes.
We expected to enrich for genes with a known function in
phagocytosis. We also predicted that we would identify novel
genes that regulate this cellular function. The cDNAs encoding
a hypothetical protein (GI:183232640), ribosomal protein L10
(GI:183234305), profilin (GI:1070154), and a LIM zinc finger
domain-containing protein (EhLimA; GI:67483282) were the most
highly enriched by selection with tubercidin-loaded erythrocytes.
The cDNA encoding profilin was isolated from 6.3% of
bacterial clones that had been transfected with episomes isolated
from trophozoite survivors. Profilin is an abundant actin mono-
mer-binding protein that plays a role in the regulation of
cytoskeleton restructuring (reviewed in [35]). Profilin also has
a known role in phagocytosis in other systems [20,36,37]. Given
the established role of profilin in phagocytosis, we did not conduct
additional studies with this gene. However, the isolation of profilin
by our screen supports the authenticity of the selection protocol. A
cDNA encoding ribosomal protein L10 was also isolated by the
screen with high frequency (8.5% of sequenced clones). L10 may
be an authentic regulator of phagocytosis or it may be represent
Table 1. Isolation of cDNAs from E. histolytica over-expressors without (Control) and with (Selected) selection with tubercidin-
charged erythrocytes.
GenInfo Identifier (GI) Number Gene Name Number of Isolates (Control) Number of Isolates (Selected)
183232640 Hypothetical protein 6 55
183234305 Ribosomal protein L10 1 8
1070154 Profilin 0 6
183233949 Ribosomal protein L7 5 6
67483282 EhLimA 0 4
183230765 Ribosomal protein L9 6 3
158992 SREHP 1 2
183230551 V-ATP synthase, subunit E 1 2
183232834 Ribsomal protein L13 0 2
67469498 Rho-activating protein 1 2
183232074 Hypothetical protein 1 1
183230481 Ribosomal protein S9 1 1
67479568 Histone H2b, putative 0 1
67481134 Ribosomal protein S25 4 1
183232219 Hypothetical protein 9 0
67479580 Alcohol dehydrogenase 7 0
732691 Alcohol dehydrogenase 3 6 0
183235741 Ribosomal protein L15 5 0
183233758 Ribosomal protein L13 4 0
183231176 Enolase, putative 4 0
183232711 Ribosomal protein S14 4 0
183232055 Ribosomal protein L17 3 0
183230950 C2-domain protein 3 0
183233207 Actin-binding protein 2 0
183233272 Serine protease inhibitor 2 0
25989681 GTPase, putative 2 0
183233845 Ribosomal protein L14 2 0
183231806 Ribosomal protein L11 1 0
183231333 Ribosomal protein L4 1 0
183230617 Ribosomal protein L23 1 0
183232892 Ribosomal protein S7 1 0
67466875 Ribosomal protein S25 1 0
183236693 Serine-rich protein 1 0
25989677 HSP70-like protein 1 0
183230634 Hypothetical protein 1 0
183234340 Ras family GTPase 1 0
Total 89 90
doi:10.1371/journal.pone.0043025.t001
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a false positive. Since over-expression of ribosomal proteins may
have profound global and non-specific effects on protein synthesis,
this gene was also not considered further for the purposes of this
study. Many ribosomal proteins were also isolated in the absence
of selection (Table 1).
The cDNA encoding a hypothetical protein was the most highly
enriched of the cDNAs and was present in 58.5% of the bacterial
clones that had been transfected with episomes isolated from
trophozoite survivors. The corresponding protein, that we named
H644, is predicted to be 304 amino acids long (33.8 kDa) and to
possess a C-terminal lysine rich region, and casein kinase II,
tyrosine kinase, protein kinase C, cAMP-dependant, and cGMP-
dependent phosphorylation sites (Fig. 3A). These phosphorylation
sites are consistent with a role in cell signaling. The protein also
possesses putative N-glycosylation and myristoylation sites
(Fig. 3A).
The cDNA encoding a LIM zinc finger-containing protein, also
known as EhLimA [38], was present in 4.2% of bacterial clones
that had been transfected with the episomes isolated from
trophozoite survivors. This protein is predicted to be 145 amino
acids long (15.9 kDa). Like other members of the LIM family
(reviewed in [39]), the protein has two putative contiguous zinc
finger domains (LIM domains) separated by a two-amino acid
hydrophobic linker (Fig. 3B). EhLimA also possesses a glutamic
acid-rich region, a PKC phosphorylation site, and an N-
myristoylation site (Fig. 3B).
Authentication of H644 and EhLimA as Negative
Regulators of Phagocytosis
Expression vectors encoding H644 or EhLimA, isolated from
the original screen, were transfected into wild-type trophozoites to
construct 2nd generation cell lines uniformly over-expressing these
proteins. Over-expression of H644 or EhLimA transcripts was
confirmed by qPCR. H644 or EhLimA transcripts exhibited a 3.1
(60.0)- and 5.6 (60.4)-fold higher abundance, respectively, in the
2nd generation transgenic cell lines as compared to parental
controls (Fig. 4).
To authenticate the identification of EhLimA or H644 as
negative regulators of phagocytosis, we exposed the 2nd generation
transgenic cell lines to 3 rounds of selection with tubercidin-
charged hRBCs. After a 48 hour recovery period we re-assessed
toxicity of the selecting agent. These cell lines exhibited increased
survival in the presence of cytotoxic erythrocytes as compared to
control cells (Fig. 5) suggesting that their isolation during the
original scheme was valid. Although the increase in survival was
not statistically significant, this degree of viability in the presence of
toxin may have been sufficient to confer enrichment of these over-
expressors during the original screen. Though we observed .3-
fold increase in expression of EhLimA or H644 in the 2nd
generation cell lines, we do not know the level of over-expression
in the initial isolates since they were not cloned. Thus, we cannot
rule out a gene dosage effect as over-expression may have been
higher in the original mutants that survived selection.
If H644 or EhLimA function as cell surface pumps, or if they
enhance the activity of cell surface pumps, general resistance to
small molecules (i.e., a multidrug resistance phenotype) may be
conferred. If this were the case, the isolation of H644 or
EhLimA over-expressors would be considered a false positive
outcome of the screen. To address this, the specificity of the
response to tubercidin-loaded hRBCs was tested by assaying the
effect of an unrelated small molecule, cycloheximide, on the
H644- and EhLimA-expressing cell lines. The transgenic cell
lines were exposed to cycloheximide and viability was de-
termined. When compared to control cells, neither transgenic
cell line exhibited increased survival in the presence of
cycloheximide (Fig. 6). This indicated that isolation of H644
or EhLimA during the original screen was not due to
a multidrug resistance phenotype characterized by non-specific
extrusion of small molecules.
To confirm that the isolation of H644 and EhLimA over-
expressors from a mixed population was the result of
a phagocytosis defect, we performed the definitive experiment
by measuring uptake of erythrocytes in the 2nd generation cell
lines. Control and mutant cell lines were exposed to hRBCs for
10 minutes, after which extracellular erythrocytes were lysed
Figure 3. Schematic of domains found in the hypothetical protein H644 and EhLimA. A. H644 is a hypothetical protein with a postulated
molecular weight of 33.8 kDa (304 amino acids). It is predicted to have a lysine-rich region (blue hexagon), a glycosylation site (gray vertical line), a N-
myristoylation site (purple vertical line), 3 casein kinase II phosphorylation sites (red flags labeled C), 5 protein kinase C phosphorylation sites (red
flags labeled P), 2 tyrosine kinase phosphorylation sites (red flags labeled Y), and 2 cAMP/cGMP-dependant protein kinase phosphorylation sites (red
flags labeled G). B. EhLimA has a molecular weight of 15.9 kDa (145 amino acids). It has an N-terminal LIM domain (orange pentagon), a C-terminal
glutamic acid-rich region (green circle), 3 protein kinase C phosphorylation sites (red flags labeled P), and a N-myristoylation site (purple vertical line).
doi:10.1371/journal.pone.0043025.g003
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hypotonically with distilled water and the level of ingested heme
was measured by spectrophotometry. Erythrophagocytosis in
H644 and EhLimA over-expressing cell lines was inhibited by
approximately 31% and 18%, respectively, when compared to
parental control cells (Fig. 7). This supports a role for these
proteins in the regulation of phagocytosis. To determine if the
transgenic cell lines expressing H644 or EhLimA possessed
a general endocytic defect, we also measured uptake of a fluid-
phase marker, FITC-dextran. Importantly, uptake of this
marker was not affected by over-expression of H644 or
EhLimA (Fig. 8). Thus, H644 and EhLimA appear to
specifically regulate the phagocytosis of erythrocytes.
Discussion
In this study we have shown that genes regulating important
virulence functions in E. histolytica can be identified using
a functional genomics approach. Since phagocytosis is an
important virulence determinant, it was chosen as the focus of
the screen. However, our goal was not to study phagocytosis per se,
but to determine the utility of over-expression screens for gene
discovery in E. histolytica. To the best of our knowledge, this is the
first forward genetics over-expression screen applied to E.
histolytica. Specifically, we adapted a high-throughput protocol to
enrich for phagocytosis mutants in a mixed population of over-
expressing cells and identified a LIM-domain-containing protein
Figure 4. qPCR confirms over-expression of H644 and EhLimA. RNA from untransfected (wild-type; WT) log phase E. histolytica trophozoites
or from trophozoites transfected with an expression vector encoding H644 or EhLimA was used for qPCR analysis of expression. The ssRNA gene was
used as a loading control. H644 and EhLimA were expressed at approximately 3.1 (60.0)- and 5.6 (60.4)-fold, respectively, over wild-type levels.
doi:10.1371/journal.pone.0043025.g004
Figure 5. Tubercidin-loaded erythrocytes are less toxic to E. histolytic cells over-expressing H644 or EhLimA. Transgenic trophozoites
were exposed to tubercidin-loaded erythrocytes (3 treatments) and viability was assessed 48 hours after treatments. The data are reported as
a percent of the starting number of viable amoebae before treatment. The data represent the mean 6 S.D of 3 trials. E. histolytica transgenic cells
exposed to tubercidin-charged hRBCs displayed increased survival as compared to untransfected wild-type (WT) cells.
doi:10.1371/journal.pone.0043025.g005
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(EhLimA) and a hypothetical protein (H644) as putative negative
regulators of phagocytosis.
E. histolytica phagocytoses apoptotic and non-apoptotic host cells
by different routes and receptors [12]. Although we did not
observe any obvious changes in morphology of tubercidin-charged
hRBCs by light microscopy, we cannot eliminate the possibility
that tubercidin induced an apoptosis-like event in these host cells.
Never-the-less, EhLimA- and H644-overexpressors were isolated
in the screen using tubercidin-loaded hRBCs (apoptotic?) and also
exhibited reduced phagocytosis of unloaded hRBCs (non-apopto-
tic). Thus, we predict that EhLimA and H644 are more general
regulators of phagocytosis participating in uptake of either
apoptotic or non-apoptotic host erythrocytes.
We also identified the actin-binding protein, profilin, using our
screen. At high concentrations, profilin prevents the polymeriza-
tion of actin [35]. Therefore, it is reasonable to hypothesize that
profilin over-expression would inhibit phagocytosis, and it was not
surprising that this protein was identified by our screen. In support
Figure 6. Cycloheximide is toxic to E. histolytica cells over-expressing H644 or EhLimA. Transgenic trophozoites were exposed to 100 nM
cycloheximide for 48 hours after which viability was assessed. The data are reported as a percent of untreated control amoebae. The data represent
the mean 6 S.D of 3 trials. Cycloheximide was toxic to both untransfected wild-type (WT) amoebae and E. histolytica transgenic cells. Therefore, cells
over-expressing H644 or EhLimA do not exhibit a multidrug resistance phenotype.
doi:10.1371/journal.pone.0043025.g006
Figure 7. Phagocytosis is reduced in E. histolytica cells over-expressing H644 or EhLimA.Wild-type (WT) or transgenic cells were incubated
with erythrocytes (hRBC:amoeba ratio; 100:1) for 10 minutes, lysed, and spectrophotometrically analyzed for internalized heme at 405 nm. The data
represent the mean6 S.D. of 4 experiments (**P,0.01; *P,0.05). Amoebae over-expressing H644 or EhLimA exhibit reduced phagocytosis of hRBCs.
doi:10.1371/journal.pone.0043025.g007
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of this, profilin over-expression reduces endocytic uptake in
murine cells [36] and in a non-pathogenic amoeba, Dictyostelium
discoideum [37]. In addition, Drosophila melanogaster [20] profilin-null
mutants exhibit increased phagocytosis. Given the established role
of profilin in phagocytosis [20,36,37], the enrichment of a profilin
over-expressor validates the reliability of the screen.
A ribosomal protein (L10) was also highly enriched in our
screen. L10 may be an authentic regulator of phagocytosis or it
may represent a false positive. It has recently been shown that
under some conditions, phagosomes fuse with auto-phagosomes.
Since auto-phagosomes originate from invaginations of the
endoplasmic reticulum [40], an organelle rich in ribosomes and
ribosomal proteins, it would not be surprising to detect ribosomal
proteins in phagosomes. Furthermore, phagosome–autophago-
some fusion during mycobacterial infection is characterized by the
transport of cytosolic ribosomal proteins into the lumen of these
organelles and the subsequent degradation of these proteins into
mycobactericidal peptides [41]. Thus, L10 may be an authentic
phagosome protein.
Since our screen was based on a functional assay, we predict
that we would not have enriched for phagosomal cargo proteins
unless these cargo proteins also specifically regulate phagosome
function. A study of E. histolytica ribosomal protein L10 [42]
revealed that this protein was localized to the nucleus and that its
over-expression suppressed growth by 60% and disrupted the AP-
1/c-Jun transcription factor complex [42]. Suppression of growth
is likely coupled with reduced metabolic requirements and, by
extension, with reduced sensitivity to metabolic toxins. Therefore,
an L10-over-expressor could have been enriched in our screen by
a slow-growth phenotype conferring reduced sensitivity to
tubercidin, a metabolic poison. In either case, it remains to be
seen if L10 authentically controls phagocytosis of erythrocytes in
E. histolytica.
In the current study, a loss-of-function phenotype (reduced
phagocytosis), coupled with viability, formed the basis of the
screen. The current screen was based on a previous scheme in
which tubercidin-charged erythrocytes were used to enrich for
phagocytosis variants from a population of macrophages chemi-
cally mutagenized with nitrosoguanidine (NG) [19]. Although it
was not possible to identify specific macrophage genes that were
altered by NG-treatment, 40 stable clones were isolated and
characterized and it was found that the majority of these cell lines
were authentic phagocytosis mutants. Only one of the 40 clones
was a false positive clone that likely survived selection by non-
specific extrusion of the toxin (i.e., multidrug resistance). This
illustrates the robustness of a selection protocol that uses toxin-
charged erythrocytes to identify mutants defective in erythropha-
gocytosis. We have combined this robustness with newer
technology that allows for the specific identification of mutated
(over-expressed) genes to identify novel phagocytosis-regulators in
E. histolytica.
Loss-of-function screens have been used in other systems to
identify genes regulating a variety of cellular functions. For
example, in Saccharomyces cerevisiae, loss-of-function screens have
uncovered genes that regulate nutrient acquisition and metabolism
[43–49], sensitivity to various forms of irradiation [50–53],
sensitivity to anti-fungal agents [54,55], and resistance to various
other small molecules, peptides, and toxins [56–60]. In Caenorhab-
ditis elegans, lethality was the readout in several large-scale genome-
wide screens [61–64]. In human HeLa cells, viability was scored in
a screen to identify genes, specifically kinases, involved in apoptosis
[65]. Our data suggest that over-expression combined with a loss-
of-function phenotype may also be valuable in gaining insight into
E. histolytica virulence.
Although transfection efficiency in E. histolytica is low, the
possibility that members of the library of over-expressing cells
harbored more than one plasmid was a caveat of our original
screen. Thus, confirming the ‘‘hits’’ was critical in our study. We
used two approaches to confirm the roles of EhLimA and H644 in
phagocytosis. First, we created 2nd generation E. histolytica cell lines
over-expressing these proteins, and we repeated the original assay
using tubercidin-charged erythrocytes. Second, we quantified
erythrophagocytosis in the new transgenic cell lines. Both lines
of experimentation confirmed the authenticity of these hits as each
Figure 8. Fluid-phase endocytosis is not reduced in E. histolytica cells over-expressing H644 or EhLimA. Wild-type (WT) or transgenic
cells were incubated with the fluid-phase marker, FITC-dextran for 30 minutes, lysed, and analyzed for internalized FITC-dextran using
spectrofluorimetry. The data represent the mean 6 S.D. of $3 experiments. Amoebae over-expressing H644 or EhLimA exhibit normal uptake of
fluid-phase marker suggesting that these cell lines do not have wide-spread defects in endocytosis.
doi:10.1371/journal.pone.0043025.g008
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2nd generation cell line exhibited increased survival in the presence
of the selection agent and decreased phagocytosis. The cell line
over-expressing H644 showed a higher level of survival in the
presence of selection and a more pronounced phagocytosis defect.
Thus, it was not surprising that H644 was isolated more frequently
than EhLimA. Since over-expression of EhLimA or H644 alone
(2nd generation cell lines) led to reduced phagocytosis, it was
unlikely that original over-expressors harbored additional plasmids
that were necessary for conferring the phenotype.
Several proteomic analyses of purified phagosomes from E.
histolytica have been carried out. Our work complements these
analyses. Marion et al. [14] conducted proteomic analysis of
purified E. histolytica phagosomes using liquid chromatography and
tandem mass spectroscopy (LC-MS/MS). Both profilin and
EhLimA were also identified as members of the E. histolytica
phagosome proteome. Thus, our functional screen extends our
knowledge by specifically identifying EhLimA and profilin as
negative regulators of phagocytosis in E. histolytica.
EhLimA has been the subject of another study in E. histolytica
[38]. In the previous report, the authors demonstrated that
EhLimA was localized to the parasite cell surface, interacted with
the cytoskeleton through its N-terminal LIM domain, and resided
in lipid rafts. In addition, the authors showed that neither
transcriptional silencing nor over-expression of EhLimA affected
growth or morphology of trophozoites. Our study advances the
understanding of the role of EhLimA in cellular functions,
specifically in phagocytosis.
EhLimA exhibits a high degree of homology with DdLimE,
a LIM-domain-containing protein from D. discoideum [66,67].
Although a role for DdLimE in phagocytosis has not been
established, several other D. discoideum LIM family proteins, LimF
and ChLim, have well-defined and opposing roles in this process
[68]. For example, over-expression of LimF or loss of ChLim
increases the rate of phagocytosis, whereas loss of LimF or over-
expression of ChLim inhibits phagocytosis. EhLimA was also
identified as a protein that was over-expressed in an avirulent
strain of E. histolytica that was incapable of inducing liver abscess in
experimentally infected rodents [69]. Erythrophagocytosis was not
inhibited in this avirulent strain; however, there were numerous
other concurrent genetic changes in this subspecies. Together,
these genetic changes likely contributed to the phenotype of this
strain.
Currently, it remains to be seen if inhibition of phagocytosis is
a direct or indirect effect of over-expression of the hypothetical
protein, H644. Although hypothetical proteins were highly
represented in the E. histolytica phagosome proteome [15,16],
H644 was not identified as a phagosome-interacting protein in
these analyses. Given the significant number of putative
phosphorylation sites in H644, this protein is predicted to have
a role in signal transduction. Indirect inhibition of phagocytosis
could occur by over-expression of a protein that is part of, or
communicates with, a signaling relay that regulates phagocytosis.
Nonetheless, the identification of H644 as a negative regulator of
phagocytosis in the current study illustrates one of the advantages
of functional genomics screens over proteomic analysis of purified
organelles. Here, we have identified a protein that may not
necessarily interact with phagosomes but exhibits a role in
regulating phagocytosis.
Other functional genomics screens using this library of over-
expressing trophozoites can be envisioned. For example, screens to
identify a different class of endocytic mutants may be conducted
by applying fluid phase toxins to the transgenic population and
characterizing the episomes isolated from survivors. Employing
fluorescent phagocytic markers and fluorescence-associated cell
sorting (FACS) could be used to isolate mutants with enhanced
phagocytosis instead of decreased phagocytosis. A high-through-
put centrifugation-based adhesion assay has recently been de-
scribed for mammalian cells [70]. The adaptation of such an assay
to examine adhesion in the population of E. histolytica over-
expressors would represent a screen that could provide insight into
another important virulence function, namely parasite-host in-
teraction.
Insight into drug resistance may be gained by selecting for
metronidazole-resistant mutants from the population of over-
expressing cells. Drug resistance is not prevalent in E. histolytica.
However, occasional reports of metronidazole failures that cannot
be attributed to a lack of patient compliance, suggest the possibility
for the development of clinical resistance [71–73]. Identification of
over-expressed genes in metronidazole-resistant isolates may paint
a picture of the propensity of this pathogen to acquire resistance to
small-molecules. Screening of small-molecule libraries for anti-
microbial agents is becoming increasingly popular [74,75]. If small
molecule inhibitors of E. histolytica growth are identified, then the
targets of such inhibitors might be rapidly discovered by sub-
sequently screening the library of over-expressing transformants
for resistant mutants.
Systematic functional genomics screens have become standard
practice in assigning gene function and have accelerated our
understanding of cell biology in both mammalian and non-
mammalian systems. Although our screen was not exhaustive, we
have demonstrated the power of functional genomics in revealing
genes regulating a virulence function in E. histolytica. Our results
also validate the E. histolytica cDNA over-expression library as
a valuable tool for functional genomics. As other high-throughput
screens are developed for E. histolytica, their application to the
library of over-expressing transformants will undoubtedly provide
rapid insight into E. histolytica pathogenicity and may reveal novel
targets for the development of drugs or vaccines.
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